Match Document Document Title
7348335 Compositions useful as inhibitors of JAK and other protein kinases  
The present invention provides a compound of formula I: or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the...
7348333 Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists  
There are described cycloalkyl derivatives of the formula (I) R 1 —Y-A-B-D-E-F-G (I)
7338959 Diamino-pyrimidines and their use as angiogenesis inhibitors  
Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well...
7335672 Vanilloid receptor ligands and their use in treatments  
Substituted pyridines and pyrimidines and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache,...
7335663 Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins  
Disclosed are compounds which bind α 4 integrins, where the α 4 integrin is preferably VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion...
7329670 Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas  
The compounds are aryl and heteroaryl substituted heterocyclic ureas of the formula A—NH—C(O)—NH—B where A is the aryl or hetaryl substituted heterocyclic group and B is an aryl or...
7329661 N-phenyl-3-pyrimidine-amine derivatives  
The invention relates to N-phenyl-2-pyrimidine-amine derivatives of formula I wherein the substituents are defined as indicated in the description, to processes for the preparation thereof, to...
7326717 Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof  
Novel pyrimidine N-oxide compounds and salts thereof, well suited for stimulating the growth of keratin fibers (e.g., the hair or the eyelashes) and/or limiting the loss thereof and/or increasing...
7326705 Heterocyclic sodium/proton exchange inhibitors and method  
Heterocyclic are provided which are sodium/proton exchange (NHE) inhibitors which have the structure wherein n is 1 to 5; X is N or C—R 5 wherein R 5 is H, halo, alkenyl, alkynyl, alkoxy,...
7323464 Pyridine and pyrimidine derivatives  
Compounds of formula (1) are described in which R a and R b is each independently a hydrogen atom or a group R c , or R a and R b together form an oxo (═O) or thio (═S) group; X is a N atom...
7319104 hPPARs activators  
Compounds of formula (1) or a pharmaceutically acceptable salt, solvate, acid isostere, or hydrolyzable ester thereof, are disclosed. Methods of making and using the compounds are also disclosed....
7312216 N-phenyl-2-pyrimidine-amine derivatives  
The invention relates to N-phenyl-2-pyrimidine-amine derivatives of formula I wherein the substituents are defined as indicated in the description, to processes for the preparation thereof, to...
7312227 Compositions useful as inhibitors of JAK and other protein kinases  
The present invention provides a compound of formula I: or a pharmaceutically acceptable salt thereof. The invention also provides pharmaceutically acceptable compositions comprising the...
7309704 Heteroaryl urea neuropeptide Y Y5 receptor antagonists  
The present invention relates to compounds represented by the structural Formula I: or a pharmaceutically acceptable salt thereof, which are useful for the treatment of metabolic and eating...
7304071 Protein kinase inhibitors and uses thereof  
Described herein are compounds that are useful as protein kinase inhibitors having the formulae I and V: or a pharmaceutically acceptable salt thereof, wherein Ring B, Z 1 , Z 2 , U, T, m, n,...
7304072 Spiro compounds  
Compounds represented by the general formula (I) wherein Ar 1 represents an aryl or heteroaryl which may be substituted; n represents 0 or 1; T, U, V and W each independently represent a...
7300933 Diazabicyclic biaryl derivatives  
This invention relates to novel diazabicyclic biaryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and...
7300940 Integrin α-v β-3 antagonists for use in imaging and therapy  
Integrin receptor antagonists whose molecular structure includes a tetrahydropyridimidinylaminoethyloxybenzoyl group on a sulfonylamino-β-alanine nucleus exhibit increased binding affinity for the...
7300941 Non-imidazole compounds  
Disclosed are novel compounds of the formula Also disclosed are pharmaceutical compositions comprising the compounds of Formula I. Also disclosed are methods of treating various diseases or...
7294635 Substituted isoquinolinones  
Isoquinolinone compounds are provided that are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
7291624 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents  
This invention relates to pyrimidine derivatives of general formula I in which R 1 , R 2 , X, A and B have the meanings that are contained in the description, as inhibitors of the...
7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents  
This invention relates to 2-heteroaryl-pyrimidine derivatives of general formula I or I f as inhibitors of the cyclin-dependent kinases, their production as well as their use as medications for...
7288544 Pyrimidine compounds useful as N-type calcium channel antagonists  
Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when...
7285560 Indole derivatives or benzimidazole derivatives for modulating IκB kinase  
The present invention relates to indole derivatives or benzimidazole derivatives, to processes for preparing such compounds, to pharmaceutical compositions comprising such compounds, and methods...
7285551 Fused-ring compounds and use thereof as drugs  
The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a...
7282504 Kinase inhibitors  
The invention relates to inhibitors of kinases, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising...
7276510 HIV replication inhibitors  
This invention concerns HIV replication inhibitors of formula the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms...
7276502 Thiazoles useful as inhibitors of protein kinases  
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of...
7273862 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives  
The present invention concerns compounds of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein -Z...
7265115 Diazabicyclic CNS active agents  
Compounds of formula I: or pharmaceutically acceptable salts thereof, are useful for controlling synaptic transmission in mammals.
7262203 Pyrimidineamines as angiogenesis modulators  
Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using...
7262202 Inhibitors of cyclin dependent kinases as anti-cancer agent  
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases...
7256192 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof  
The present invention relates to an aromatic diamide derivative represented by the general formula (I): [A 1 is optionally substituted (C 1 -C 8 )alkylene group, (C 3 -C 8 )alkenylene...
7253174 N-heterocyclic inhibitors of TNF-α expression  
N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula (I): Methods...
7244740 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection  
The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their...
7244735 Heterocyclic protein kinase inhibitors and uses thereof  
Described herein are compounds that are useful as protein kinase inhibitors of formula I: or a pharmaceutically acceptable salt thereof, wherein Ring B, Z 1 , Z 2 , U, p, Q, R 1 , R 2 , R 3 ,...
7241756 Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus  
A method for the treatment of diabetes mellitus, especially Type 2 diabetes and conditions associated with diabetes mellitus in a mammal such as a human, which method comprises administering an...
7241458 Antiviral compositions  
The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These...
7241769 Pyrimidines as PLK inhibitors  
The present invention comprises compounds of general formula (1) wherein A, X, Y, Z, R a , R b , R c , R 1 , R 2 and R 3 are defined as in claim 1 , which are suitable for the treatment of...
7238697 Pyridylpyrimidines for use as pesticides  
The present invention relates to novel pyridylpyrimidines of the formula in which R 1 , R 2 , X, n, Y, Z and R have the meanings given in the disclosure, to a plurality of processes for...
7235561 Compound and a composition including such a compound  
This invention relates to pyrimidine derivatives of general formula I in which R 1 , R 2 , X, A and B have the meanings that are contained in the description, as inhibitors of the...
7232825 Phenylaminopyrimidine derivatives and methods of use  
The present invention relates to phenylaminopyrimidine derivatives, processes for their preparation, pharmaceutical compositions containing them as active ingredient, methods for the treatment of...
7230002 Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof  
The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors their analogs, isomers, pharmaceutical compositions, therapeutic uses and methods of making the same.
7226919 Compositions useful as inhibitors of protein kinases  
The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of...
7220736 Pyrimidine compounds  
A cyclic compound of the formula (I) or a pharmacologically acceptable salt thereof, wherein X is ═CH— or ═N—, Y is —NH—, —NR 4 —, —S—, —O—, —CH═N—,...
7217716 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists  
Compounds represented by Formula (I): (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain
7208499 Pyrimidine derivatives for the treatment of abnormal cell growth  
The present invention relates to a compound of the formula 1 wherein A and Ar are as defined herein. Such novel pyrimidine derivatives are useful in the treatment of abnormal cell growth, such...
7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives  
Fungicidal compounds of Formula (I) wherein m is 0, 1, 2 or 3; n and p are independently of each other 0 or 1; R 1 is halogen, optionally substituted alkyl, optionally substituted alkoxy,...
7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity  
The present invention relates to a series of novel substituted 5-alkynyl pyrimidines, pharmaceutical compositions which contain them, methods for their preparation, and their use in therapy,...
7205310 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4  
Disclosed are compounds which bind VLA-4 and/or LPAM-1. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4 and/or LPAM-1. Such...